163 related articles for article (PubMed ID: 30608898)
1. An evolving spectrum of diabetes in a woman with GCK-MODY.
Garrahy A; Mijares Zamuner MB; Byrne MM
Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30608898
[TBL] [Abstract][Full Text] [Related]
2. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
3. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
Østoft SH
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
[TBL] [Abstract][Full Text] [Related]
4. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
Pal A; Farmer AJ; Dudley C; Selwood MP; Barrow BA; Klyne R; Grew JP; McCarthy MI; Gloyn AL; Owen KR
Diabetes Care; 2010 Feb; 33(2):252-7. PubMed ID: 19933992
[TBL] [Abstract][Full Text] [Related]
6. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
7. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
[TBL] [Abstract][Full Text] [Related]
8. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
[TBL] [Abstract][Full Text] [Related]
9. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
10. TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.
Demiral M; Çelebi HBG; Cander S; Yerci O; Eren E; Demirbilek H
Acta Endocrinol (Buchar); 2022; 18(4):458-465. PubMed ID: 37152879
[TBL] [Abstract][Full Text] [Related]
11. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
12. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives.
Rudland VL
Diabetes Metab Syndr Obes; 2019; 12():1081-1089. PubMed ID: 31372018
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
[TBL] [Abstract][Full Text] [Related]
15. A novel genetic mutation in a Portuguese family with GCK-MODY.
Almeida C; Silva SR; Garcia E; Leite AL; Teles A; Campos RA
J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):129-33. PubMed ID: 23843579
[TBL] [Abstract][Full Text] [Related]
16. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds.
Flack JR; Ross GP; Cheung NW
Diabet Med; 2015 Dec; 32(12):1596-601. PubMed ID: 26043405
[TBL] [Abstract][Full Text] [Related]
17. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
18. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
Liu J; Xiao X; Zhang Q; Yu M
J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in GCK gene: Beware of SGA child with diabetic mother.
Tagliaferri F; Grosso C; Balbo M; Bracciolini G; Bertelli E; Secco A; Salina A; Aloi C; Gallo M; Felici E
Diabetes Res Clin Pract; 2021 Nov; 181():109081. PubMed ID: 34627944
[TBL] [Abstract][Full Text] [Related]
20. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
